Encrypted login | home

Program Information

Automatic Adaptive Per-Operative Re-Planning for HDR Prostate Brachytherapy - a Simulation Study On Errors in Needle Positioning

no image available
M Borot de Battisti

M Borot de Battisti1*, M Maenhout1 , B Denis de Senneville1,2 , G Hautvast3 , D Binnekamp3 , J J W Lagendijk1 , M Van Vulpen1 , M A Moerland1 (1) University Medical Center Utrecht, Dept. of Radiotherapy, Utrecht, The Netherlands (2) IMB, UMR 5251 CNRS/University of Bordeaux, France (3) Philips Group Innovation - Biomedical Systems, Eindhoven, The Netherlands


TU-AB-201-5 (Tuesday, July 14, 2015) 7:30 AM - 9:30 AM Room: 201

Purpose: To develop adaptive planning with feedback for MRI-guided focal HDR prostate brachytherapy with a single divergent needle robotic implant device. After each needle insertion, the dwell positions for that needle are calculated and the positioning of remaining needles and dosimetry are both updated based on MR imaging.

Methods: Errors in needle positioning may occur due to inaccurate needle insertion (caused by e.g. the needle’s bending) and unpredictable changes in patient anatomy. Consequently, the dose plan quality might dramatically decrease compared to the preplan. In this study, a procedure was developed to re-optimize, after each needle insertion, the remaining needle angulations, source positions and dwell times in order to obtain an optimal coverage (D95% PTV>19 Gy) without exceeding the constraints of the organs at risk (OAR) (D10% urethra<21 Gy, D1cc bladder<12 Gy and D1cc rectum<12 Gy). Complete HDR procedures with 6 needle insertions were simulated for a patient MR-image set with PTV, prostate, urethra, bladder and rectum delineated. Random angulation errors, modeled by a Gaussian distribution (standard deviation of 3 mm at the needle’s tip), were generated for each needle insertion. We compared the final dose parameters for the situations (I) without re-optimization and (II) with the automatic feedback.

Results: The computation time of replanning was below 100 seconds on a current desk computer. For the patient tested, a clinically acceptable dose plan was achieved while applying the automatic feedback (median(range) in Gy, D95% PTV: 19.9(19.3-20.3), D10% urethra: 13.4(11.9-18.0), D1cc rectum: 11.0(10.7-11.6), D1cc bladder: 4.9(3.6-6.8)). This was not the case without re-optimization (median(range) in Gy, D95% PTV: 19.4(14.9-21.3), D10% urethra: 12.6(11.0-15.7), D1cc rectum: 10.9(8.9-14.1), D1cc bladder: 4.8(4.4-5.2)).

Conclusion: An automatic guidance strategy for HDR prostate brachytherapy was developed to compensate errors in needle positioning and improve the dose distribution. Without re-optimization, target coverage and OAR constraints may not be achieved.

Funding Support, Disclosures, and Conflict of Interest: M. Borot de Battisti is funded by Philips Medical Systems Nederland B.V. M. Moerland is principal investigator on a contract funded by Philips Medical Systems Nederland B.V. G. Hautvast and D. Binnekamp are full-time employees of Philips Medical Systems Nederland B.V.

Contact Email: